Home › Funds › Two Sigma Investments › RCEL
Two Sigma Investments position in RCEL
AVITA MEDICAL INC · Health Care
Latest position (Q4 2023)11.10K sh
Reported value held$152.25K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 58.11K | $276.00K | New |
| Q3 2022 | 14.86K | $78.00K | Reduce |
| Q4 2022 | 45.24K | $298.56K | Add |
| Q1 2023 | 119.86K | $1.67M | Add |
| Q2 2023 | 144.44K | $2.46M | Add |
| Q3 2023 | 81.72K | $1.19M | Reduce |
| Q4 2023 | 11.10K | $152.25K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RCEL
- Vanguard Group 1.44M sh · $4.98M · Q4 2025
- BlackRock Inc 564.95K sh · $2.33M · Q2 2026
- Geode Capital Management 339.82K sh · $1.40M · Q2 2026
- Marshall Wace 338.39K sh · $1.40M · Q2 2026
- AQR Capital Management 321.01K sh · $1.33M · Q2 2026
- Morgan Stanley 200.46K sh · $827.91K · Q2 2026
- UBS Group AG 84.03K sh · $347.06K · Q2 2026
- Goldman Sachs Group 76.74K sh · $316.92K · Q2 2026
- Northern Trust Corp 68.97K sh · $284.86K · Q2 2026
- Arrowstreet Capital 60.75K sh · $250.88K · Q2 2026
- Bank of America Corp 51.67K sh · $213.38K · Q2 2026
- Fidelity Management & Research (FMR) 32.52K sh · $134.29K · Q2 2026